$SNPS

LEE JANET sold $575K of SNPS

LEE JANET (GC & Corporate Secretary) sold 1,144 shares of SYNOPSYS INC (SNPS) at an average of $502.52 ($502.40–$502.64, $0.57M total) across 2 trades on 2026-10-06.

Original reporting
SEC EDGAR · LEE JANET
Published Oct 7, 2026, 10:35 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 7, 2026, 10:40 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$SNPS
Neutral
high confidence
Mentioned
$SNPS
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SNPSNeutralLow
01

Why it matters

The filing provides a factual update on insider holdings but lacks material significance.

02

Market read

Routine insider sale with limited market impact.

03

What to watch

No change in company fundamentals; insider retains a sizable position.

Relevance 5/10Novelty 4/10Timing: same-day filing

Background

SEC Form 4 filing discloses insider transactions for public companies.

Company-level read

Ticker impact

$SNPSNeutralHigh confidence
Context

Form 4 shows corporate secretary Janet Lee sold 1,144 shares for $574,685, reducing her stake to 16,534 shares.

Expected impact

slight downward pressure as the market prices the insider sell

Evidence & confidence

The transaction amount is under $1 M and represents a small percentage of total float, so impact is limited.

Market effects

None

None

None

Counterpoint

The sale could be a routine liquidity event, not a signal of concern.

Key entities

  • Synopsys Inc.

    Developer of software integrity solutions, ticker SNPS.

  • Janet Lee

    Corporate Secretary and officer at Synopsys.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$SNPSMed

Why Should You Think About Synopsys Differently Now?

Synopsys (SNPS) trades at 80.8x P/E, focusing on AI-driven chip design and Ansys. Its IP business, which underperformed due to export restrictions and customer challenges, returned to growth in Q3 2026. Ansys revenue was 1.5x Design IP's revenue in the same quarter. Management highlights a shift to a licensing-plus-royalties model, with a $1B+ deal with Amazon.

$SNPSMed

S&P lifts Synopsys to ’BBB+’ as chip-design leader capitalizes on AI demand

S&P Global Ratings upgraded Synopsys Inc's credit rating to 'BBB+' from 'BBB', citing strong long-term growth prospects driven by AI demand. The company expects mid-teens revenue growth through 2029 and improved profitability, with 2029 EBITDA margin projected at 49%. Synopsys is also accelerating cost synergies from its Ansys acquisition and expanding commercial traction, including a $1B+ contract with Amazon.

$AMZNMedAI 8/10

Amazon and Synopsys seal $1bn technology partnership

Amazon and Synopsys have signed a $1 billion deal to accelerate Amazon's custom silicon innovation and advance AI products and cloud infrastructure. The multi-year agreement builds on 15 years of collaboration, with Synopsys providing application-optimized silicon IP. Amazon's Peter DeSantis highlighted the impact of custom silicon on AWS, while Synopsys' Sassine Ghazi emphasized the partnership's role in shaping AI-native engineering.

$SNPSMed

Morgan Stanley Thinks Synopsys’ AI Story Isn’t Priced In

Morgan Stanley raised its price target for Synopsys to $574 from $500, forecasting fiscal 2027 EPS of $19.12. The firm believes Synopsys' AI story isn't fully priced in, but a re-rating depends on execution and proof of usage revenue growth. Investors will watch for metrics like customer retention and contracted backlog.